Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms

Author(s): Schmitz-Hübsch T, Coudert M, Bauer P, Giunti P, Globas C, et al.


Objective:To identify factors that determine disease severity and clinical phenotype of the most common spinocerebellar ataxias (SCAs), we studied 526 patients with SCA1, SCA2, SCA3. or SCA6.

Methods:To measure the severity of ataxia we used the Scale for the Assessment and Rating of Ataxia (SARA). In addition, nonataxia symptoms were assessed with the Inventory of Non-Ataxia Symptoms (INAS). The INAS count denotes the number of nonataxia symptoms in each patient.

Results:An analysis of covariance with SARA score as dependent variable and repeat lengths of the expanded and normal allele, age at onset, and disease duration as independent variables led to multivariate models that explained 60.4% of the SARA score variance in SCA1, 45.4% in SCA2, 46.8% in SCA3, and 33.7% in SCA6. In SCA1, SCA2, and SCA3, SARA was mainly determined by repeat length of the expanded allele, age at onset, and disease duration. The only factors determining the SARA score in SCA6 were age at onset and disease duration. The INAS count was 5.0 +/- 2.3 in SCA1, 4.6 +/- 2.2 in SCA2, 5.2 +/- 2.5 in SCA3, and 2.0 +/- 1.7 in SCA6. In SCA1, SCA2, and SCA3, SARA score and disease duration were the strongest predictors of the INAS count. In SCA6, only age at onset and disease duration had an effect on the INAS count.

Conclusions:Our study suggests that spinocerebellar ataxia (SCA) 1, SCA2, and SCA3 share a number of common biologic properties, whereas SCA6 is distinct in that its phenotype is more determined by age than by disease-related factors.

Similar Articles

Molecular epidemiology of spinocerebellar ataxia type 6

Author(s): Craig K, Keers SM, Archibald K, Curtis A, Chinnery PF

Spinocerebellar ataxia type 6

Author(s): Matsumura R, Futamura N, Fujimoto Y, Yanagimoto S, Horikawa H, et al.

SCA6 mutation analysis in a large cohort of the Japanese patients with late-onset pure cerebellar ataxia

Author(s): Yabe I, Sasaki H, Matsuura T, Takada A, Wakisaka A, et al.

The cerebellum and cognition

Author(s): Globas C, Bösch S, Zühlke Ch, Daum I, Dichgans J, et al.

Early-onset cerebellar atrophy associated with mutation in the CACNA1A gene

Author(s): Naik S, Pohl K, Malik M, Siddiqui A, Josifova D

Molecular features of the CAG repeats of spinocerebellar ataxia 6 (SCA6)

Author(s): Matsuyama Z, Kawakami H, Maruyama H, Izumi Y, Komure O, et al.

Spinocerebellar ataxia type 6

Author(s): Geschwind DH, Perlman S, Figueroa KP, Karrim J, Baloh RW, et al.

A clinical and genetic study in a large cohort of patients with spinocerebellar ataxia type 6

Author(s): Takahashi H, Ishikawa K, Tsutsumi T, Fujigasaki H, Kawata A, et al.

Meiotic instability of the CAG repeats in the SCA6/CACNA1A gene in two Japanese SCA6 families

Author(s): Shimazaki H, Takiyama Y, Sakoe K, Amaike M, Nagaki H, et al.

Pathogenic effect of an intermediate-size SCA-6 allele (CAG)(19) in a homozygous patient

Author(s): Mariotti C, Gellera C, Grisoli M, Mineri R, Castucci A, et al.

Japanese families with autosomal dominant pure cerebellar ataxia map to chromosome 19p13

Author(s): Ishikawa K, Tanaka H, Saito M, Ohkoshi N, Fujita T, et al.